IRIS
SCUTERI, DAMIANA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.025
AS - Asia 1.262
EU - Europa 608
SA - Sud America 249
Continente sconosciuto - Info sul continente non disponibili 150
AF - Africa 33
OC - Oceania 12
Totale 4.339
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.894
SG - Singapore 568
IT - Italia 311
CN - Cina 298
BR - Brasile 200
IN - India 110
VN - Vietnam 96
BD - Bangladesh 69
GB - Regno Unito 63
CA - Canada 48
RU - Federazione Russa 45
DE - Germania 42
HK - Hong Kong 36
FI - Finlandia 23
SE - Svezia 22
IL - Israele 20
NL - Olanda 17
MX - Messico 16
SV - El Salvador 16
EC - Ecuador 15
HN - Honduras 15
AR - Argentina 13
FR - Francia 13
SC - Seychelles 13
IQ - Iraq 12
PL - Polonia 11
UA - Ucraina 11
TR - Turchia 10
EE - Estonia 9
ES - Italia 9
ZA - Sudafrica 9
CR - Costa Rica 8
IE - Irlanda 8
AT - Austria 7
ID - Indonesia 7
JP - Giappone 7
PE - Perù 7
AU - Australia 6
CW - ???statistics.table.value.countryCode.CW??? 6
GT - Guatemala 6
NI - Nicaragua 6
NZ - Nuova Zelanda 6
PR - Porto Rico 6
TT - Trinidad e Tobago 6
CO - Colombia 5
RO - Romania 5
TW - Taiwan 5
CL - Cile 4
EU - Europa 4
MA - Marocco 3
NP - Nepal 3
PK - Pakistan 3
TH - Thailandia 3
XK - ???statistics.table.value.countryCode.XK??? 3
BY - Bielorussia 2
HR - Croazia 2
IR - Iran 2
JO - Giordania 2
PS - Palestinian Territory 2
PY - Paraguay 2
TN - Tunisia 2
VE - Venezuela 2
AE - Emirati Arabi Uniti 1
AG - Antigua e Barbuda 1
AM - Armenia 1
AO - Angola 1
AZ - Azerbaigian 1
BN - Brunei Darussalam 1
BO - Bolivia 1
BS - Bahamas 1
CH - Svizzera 1
CI - Costa d'Avorio 1
CY - Cipro 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
EG - Egitto 1
ET - Etiopia 1
GE - Georgia 1
GP - Guadalupe 1
LT - Lituania 1
LV - Lettonia 1
MD - Moldavia 1
MK - Macedonia 1
MU - Mauritius 1
OM - Oman 1
PH - Filippine 1
PT - Portogallo 1
SA - Arabia Saudita 1
TG - Togo 1
Totale 4.202
Salva come PNG Salva come JPEG
Città #
San Jose 447
Ashburn 197
Dallas 175
Singapore 174
Santa Clara 118
Bengaluru 89
Hefei 88
Council Bluffs 87
Beijing 60
Phoenix 50
Chandler 48
Milan 47
Ho Chi Minh City 44
Princeton 39
Lawrence 38
Chicago 37
London 37
Hong Kong 34
Los Angeles 26
New York 25
Hanoi 22
Wilmington 22
São Paulo 21
Catanzaro 20
Munich 18
Rome 18
Helsinki 16
San Salvador 14
Naples 12
Redwood City 12
Des Moines 11
Montreal 11
Palermo 10
Brooklyn 9
Warsaw 9
Ann Arbor 8
Atlanta 8
Birmingham 8
Boston 8
Toronto 8
Chennai 7
Florence 7
Lima 7
Ottawa 7
Turku 7
Vallefiorita 7
Washington 7
Amsterdam 6
Mexico City 6
San Francisco 6
San Pedro Sula 6
Shenzhen 6
Tokyo 6
Willemstad 6
Boardman 5
Bologna 5
Buffalo 5
Catania 5
Dublin 5
Guangzhou 5
Johannesburg 5
Managua 5
Manchester 5
Quito 5
Rio de Janeiro 5
San José 5
St Petersburg 5
The Dalles 5
Assago 4
Auckland 4
Charlotte 4
Mumbai 4
Orem 4
Palizzi Marina 4
San Ferdinando 4
Shanghai 4
Springfield 4
Stockholm 4
Taipei 4
Tegucigalpa 4
Ankara 3
Aversa 3
Baghdad 3
Bogotá 3
Brasília 3
Columbus 3
Curitiba 3
Erbil 3
García 3
Guatemala City 3
Hackney 3
Haiphong 3
Horia 3
Itaquaquecetuba 3
Las Vegas 3
Louisville 3
Monza 3
Philadelphia 3
Reggio Calabria 3
Rende 3
Totale 2.394
Salva come PNG Salva come JPEG
Nome #
Effects of Palmitoylethanolamide (PEA) on Nociceptive, Musculoskeletal and Neuropathic Pain: Systematic Review and Meta-Analysis of Clinical Evidence 185
Translational Impact of Genetics and Epigenetics of CGRP System on Chronic Migraine Treatment with Onabotulinumtoxin A and Other Biotech Drugs 97
Benefits and risks associated with cannabis and cannabis derivatives use 88
Anxiolytic-Like Effects of Bergamot Essential Oil Are Insensitive to Flumazenil in Rats. 77
Efficacy of therapeutic intervention with NanoBEO to manage agitation and pain in patients suffering from severe dementia: a pilot clinical trial 75
Pharmacoutilization data-driven artificial intelligence–assisted diagnosis algorithm to improve the pharmacological treatment of pain and agitation in patients suffering from severe dementia 73
Neuropharmacological Properties of the Essential Oil of Bergamot for the Clinical Management of Pain-Related BPSDs. 68
Antinociceptive effect of inhalation of the essential oil of bergamot in mice 65
Pain assessment and treatment in dementia at the time of coronavirus disease covid-19 65
2-pentadecyl-2-oxazoline prevents cognitive and social behaviour impairments in the Amyloid β-induced Alzheimer-like mice model: Bring the α2 adrenergic receptor back into play 63
Clinical and Market Analysis of NanoBEO: A Public-Worth, Innovative Therapy for Behavioral and Psychological Symptoms of Dementia (BPSD)—Emerging Evidence and Its Implications for a Health Technology Assessment (HTA) and Decision-Making in National Health Systems 63
New Trends in Migraine Pharmacology: Targeting Calcitonin Gene-Related Peptide (CGRP) With Monoclonal Antibodies. 63
Genetic variants of CGRP signaling pathway in migraine: impact on novel therapeutics 62
Benefits and risks associated with cannabis and cannabis derivatives use 62
Neuropharmacology of the Neuropsychiatric Symptoms of Dementia and Role of Pain: Essential Oil of Bergamot as a Novel Therapeutic Approach. 61
Impact of nutraceuticals on glaucoma: A systematic review 61
Antispasmodic Effect of Bergamot Essential Oil on Rat Isolated Gut Tissues 60
Focus on zavegepant: the first intranasal third-generation gepant 60
Aging brain: In search for better neurotherapeutics 59
Opioids in Post-stroke Pain: A Systematic Review and Meta-Analysis 59
Aromatherapy and Aromatic Plants for the Treatment of Behavioural and Psychological Symptoms of Dementia in Patients with Alzheimer's Disease: Clinical Evidence and Possible Mechanisms 56
Efficacy and safety of mAbs anti-CGRP/CGRP R (eptinezumab and erenumab) or atogepant in combination with onabotulinumtoxinA in refractory chronic migraine: a clinical trial protocol 55
Biphasic Hormetic-like Effect of Lebecetin, a C-type Lectin of Snake Venom, on Formalin-induced Inflammation in Mice 54
New trends in pain research: from basic research to clinical translation 53
Role of 5-HT1A receptor in the anxiolytic-relaxant effects of bergamot essential oil in rodent 52
Comparing eptinezumab with onabotulinumtoxinA in the treatment of chronic migraine: a real-world evidence study 52
Evidence on the neuroprotective properties of brimonidine in glaucoma 51
Analgesic Characteristics of NanoBEO Released by an Airless Dispenser for the Control of Agitation in Severe Dementia 50
Bergamot Essential Oil Attenuates Anxiety-Like Behaviour in Rats 50
Effects of Aging on Formalin-Induced Pain Behavior and Analgesic Activity of Gabapentin in C57BL/6 Mice 49
Proposal of combination therapies to treat refractory chronic migraine 49
Basic, Translational, and Clinical Research on Dementia 48
Behavioral Effects of Continuously Administered Bergamot Essential Oil on Mice With Partial Sciatic Nerve Ligation 48
Pattern of treatment of behavioural and psychological symptoms of dementia and pain: evidence on pharmacoutilization from a large real-world sample and from a centre for cognitive disturbances and dementia 48
Pattern of triptans use: A retrospective prescription study in Calabria, Italy 48
Bergamot rehabilitation AgaINst agitation in dementia (BRAINAID): Study protocol for a randomized, double-blind, placebo-controlled trial to assess the efficacy of furocoumarin-free bergamot loaded in a nanotechnology-based delivery system of the essential oil in the treatment of agitation in elderly affected by severe dementia 48
Efficacy of Essential Oils in Relieving Cancer Pain: A Systematic Review and Meta-Analysis 47
Combination of anti-CGRP/CGRP-R mAbs with onabotulinumtoxin A as a novel therapeutic approach for refractory chronic migraine: a retrospective study of real-world clinical evidence and a protocol for a double-blind, randomized clinical trial to establish the efficacy and safety 47
Contribution of Histamine to Nociceptive Behaviors Induced by Intrathecally Administered Cholecystokinin-8 46
Aromatherapy in Stroke Patients: Is it Time to Begin? 45
Is there a rational basis for cannabinoids research and development in ocular pain therapy? A systematic review of preclinical evidence 44
Pain and agitation treatment in severe dementia patients: The need for Italian Mobilization–Observation–Behavior–Intensity–Dementia (I-MOBID2) pain scale translation, adaptation and validation with psychometric testing 44
CB1R, CB2R and TRPV1 expression and modulation in in vivo, animal glaucoma models: A systematic review 44
Aging Brain: In Search of Better Neurotherapeutics 43
The need for better access to pain treatment: learning from drug consumption trends in the USA. 43
New trends in pharmacological control of neuropsychiatric symptoms of dementia 43
Development and translation of nanobeo, a nanotechnology-based delivery system of bergamot essential oil deprived of furocumarins, in the control of agitation in severe dementia 42
Essential oils for the control of the neuropsychiatric symptoms of dementia. A pharmacotechnological appraisal 41
Pooled Analysis of Real-World Evidence Supports Anti-CGRP mAbs and OnabotulinumtoxinA Combined Trial in Chronic Migraine 41
Editorial: “Novel Pain Therapeutics: From Basic Research to Clinical Translation and Rehabilitation” 41
GABAA/Benzodiazepine Receptor Complex in the Dorsal Hippocampus Mediates the Effects of Chrysin on Anxiety-Like Behaviour in Female Rats 41
Dementia and COVID-19: A Case Report and Literature Review on Pain Management 40
Eptinezumab for the treatment of migraine 40
Role of CGRP pathway polymorphisms in migraine: a systematic review and impact on CGRP mAbs migraine therapy 40
Homo-AMPA in the periaqueductal grey modulates pain and rostral ventromedial medulla activity in diabetic neuropathic mice 39
Safety of Onabotulinumtoxin A in Chronic Migraine: A Systematic Review and Meta-Analysis of Randomized Clinical Trials 38
Translational Value of the Transdermal Administration of Bergamot Essential Oil and of Its Fractions 38
Preclinical Characterization of Antinociceptive Effect of Bergamot Essential Oil and of Its Fractions for Rational Translation in Complementary Therapy 38
Efficacy of essential oils in pain: A systematic review and meta-analysis of preclinical evidence 38
Exploitation of thermal sensitivity and hyperalgesia in a mouse model of dystonia 38
Essential oils-induced analgesia and related translation for the management of agitation in dementia 37
Scopolamine-Induced Memory Impairment in Mice: Effects of PEA-OXA on Memory Retrieval and Hippocampal LTP 37
Role of Spinal Cholecystokinin Octapeptide, Nociceptin/Orphanin FQ, and Hemokinin-1 in Diabetic Allodynia 37
Evidence for accuracy of pain assessment and painkillers utilization in neuropsychiatric symptoms of dementia in Calabria region, Italy 37
Pharmacokinetic interactions between herbal medicines and drugs: Their mechanisms and clinical relevance 37
Requirements for Translation in Clinical Trials of Aromatherapy: The Case of the Essential Oil of Bergamot (BEO) for Management of Agitation in Severe Dementia 37
Evaluation of putative differences in vessel density and flow area in normal tension and high-pressure glaucoma using OCT-angiography 36
ROBOCOP (ROBOtic Care of Poststroke Pain): Study Protocol for a Randomized Trial to Assess Robot-Assisted Functional and Motor Recovery and Impact on Poststroke Pain Development 36
TRANSLATION OF BERGAMOT ESSENTIAL OIL IN CLINICAL TRIAL FOR CONTROL OF BEHAVIOURAL AND PSYCHOLOGICAL SYMPTOMS OF DEMENTIA 36
Pharmacotechnological Advances for Clinical Translation of Essential Oils for the Treatment of Pain and Agitation in Severe Dementia 35
Effect of genotype on individual response to the pharmacological treatment of glaucoma: a systematic review and meta-analysis 35
Progress in the Treatment of Migraine Attacks: From Traditional Approaches to Eptinezumab 35
Dementia therapeutics and cognitive rehabilitation 34
PEA-OXA ameliorates allodynia, neuropsychiatric and adipose tissue remodeling induced by social isolation 34
Hericenone C attenuates the second phase of formalin-induced nociceptive behavior by suppressing the accumulation of CD11c-positive cells in the paw epidermis via phosphorylated P65 34
Real world considerations for newly approved CGRP receptor antagonists in migraine care 33
Opioids Resistance in Chronic Pain Management 33
Targeting Neuroplasticity for the Management of Pain and Agitation in Alzheimer’s Disease via Bergamot Nanotherapy 33
Effect of gabapentin in a neuropathic pain model in mice overexpressing human wild-type or human mutated torsin a 33
Unbiased research is needed for rational translation of essential oils in clinic 32
Motor behavior induced by bergamot essential oil in experimental tasks is differentially modulated by pretreatment with metabotropic glutamate receptor 2/3 or 5 antagonists 32
NAbiximols Clinical Translation To the treatment of Pain and Agitation In Severe Dementia (NACTOPAISD): Clinical trial protocol 31
Pharmacological Treatment of Pain and Agitation in Severe Dementia and Responsiveness to Change of the Italian Mobilization-Observation-Behavior-Intensity-Dementia (I-MOBID2) Pain Scale: Study Protocol 31
Diabetic retinopathy and age-related macular degeneration: a survey of pharmacoutilization and cost in Calabria, Italy. 28
Exploitation of Autophagy Inducers in the Management of Dementia: A Systematic Review 25
Transgenic Mice for the Translational Study of Neuropathic Pain and Dystonia 25
Editorial: Plant secondary metabolites: Potential therapeutic implications in neuropsychiatric disorders 24
Epigenetic and nanotechnology alliance to fight stroke-induced brain damage 21
Chronic migraine management with onabotulinumtoxinA and anti-CGRP/R monoclonal antibodies in an Italian real-world setting: update on therapeutic appropriateness and an emerging role of pharmacy 20
Epigenetics in migraine: the Junior Editorial Board Members’ vision 18
Gas Chromatography–Mass Spectroscopy (GC-MS) Simultaneous Determination of Limonene, Linalool, and Linalyl Acetate in Rat Plasma Following Transdermal Administration of the Essential Oil of Bergamot Loaded Onto Solid Lipid Nanoparticles (NanoBEO) 17
Risk factors associated to disability in primary headaches: a systematic review to inform future iterations of the Global Burden of Disease Study 15
Pharmacological mechanisms underlying neurovascular alterations related to resistant and refractory migraine: CGRP pathways and beyond 14
Hericenone C exhibits anti-nociceptive effects through RORα-mediated suppression of TLR4 transcription 14
Awareness, attitudes, and clinical practices related to medication-overuse headache among Italian pharmacists: results from a cross-sectional survey 13
Real-World Evolution of Prescribing Patterns and Safety Profiles of Biologic and Targeted Synthetic Therapies in Inflammatory Rheumatic Diseases: A Comparative Study Between 2018–2019 and 2023–2024 13
Positioning rimegepant in migraine prophylaxis: updated evidence and emerging perspectives 11
Beyond triptans in menstrual migraine: the emerging role of CGRP-targeted therapies 8
Totale 4.339
Salva come PNG Salva come JPEG
Categoria #
all - tutte 37.185
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 37.185
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022102 0 0 0 0 5 22 9 21 6 15 23 1
2022/2023229 78 9 7 9 17 30 6 21 23 8 17 4
2023/2024194 44 18 14 10 14 45 7 6 4 5 24 3
2024/2025908 125 58 35 21 87 104 20 18 157 44 82 157
2025/20262.014 86 314 198 280 190 77 261 131 205 108 53 111
2026/2027747 28 112 272 240 95 0 0 0 0 0 0 0
Totale 4.339